{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:47:30Z","timestamp":1789015650706,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pneurobio.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T14:48:23Z","timestamp":1358779703000},"page":"114-123","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease"],"prefix":"10.1016","volume":"110","author":[{"given":"Kevin R.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lynn Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard H.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2012.12.001_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt2","article-title":"Alzheimer's disease therapeutic research: the path forward","volume":"1","author":"Aisen","year":"2009","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0015","series-title":"World Alzheimer Report 2010: Global Economic Impact of Dementia","author":"Alzheimer's Disease International","year":"2010"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nurt.2008.05.009","article-title":"Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease","volume":"5","author":"Bateman","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0030","series-title":"Principles of Biomedical Ethics","author":"Beauchamp","year":"2009"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuron.2010.09.041","article-title":"Tangles of neurogenetics, neuroethics, and culture","volume":"68","author":"Brief","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0045","series-title":"Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans","author":"Canadian Institutes of Health Research","year":"2010"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/014662168300700301","article-title":"The cost of dichotomization","volume":"7","author":"Cohen","year":"1983","journal-title":"Applied Psychological Measurement"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/1467-9566.00176","article-title":"\u2018There's this thing in our family\u2019: predictive testing and the construction of risk for Huntington's Disease","volume":"21","author":"Cox","year":"1999","journal-title":"Sociology of Health and Illness"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.GIM.0000132679.92238.58","article-title":"Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study","volume":"6","author":"Cupples","year":"2004","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cct.2006.02.007","article-title":"The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia","volume":"27","author":"DeKosky","year":"2006","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0075","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/01.gim.0000250197.44245.a3","article-title":"Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study","volume":"8","author":"Eckert","year":"2006","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0080","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","article-title":"What makes clinical research ethical?","volume":"283","author":"Emanuel","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0085","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0090","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1073\/pnas.1015950108","article-title":"Exercise training increases size of hippocampus and improves memory","volume":"108","author":"Erickson","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrd3288","article-title":"Alzheimer's failure raises questions about disease-modifying strategies","volume":"9","author":"Extance","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2012.12.001_bib0100","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1017\/S0317167100005631","article-title":"Primary prevention and delay of onset of AD\/dementia","volume":"34","author":"Feldman","year":"2007","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0105","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000159743.08996.99","article-title":"Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease","volume":"64","author":"Fox","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors","volume":"13","author":"Goldman","year":"2011","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0809578","article-title":"Disclosure of APOE genotype for risk of Alzheimer's disease","volume":"361","author":"Green","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0125","first-page":"11","article-title":"Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism","volume":"25","author":"Horng","year":"2003","journal-title":"IRB; A Review of Human Subjects Research"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jalz.2007.07.010","article-title":"Genetics and dementia: risk factors, diagnosis, and management","volume":"3","author":"Hsiung","year":"2007","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0135","series-title":"International Harmonized Tripartite Guideline: General Considerations for Clinical Trials: E8","author":"ICH Expert Working Group","year":"1997"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0317167100005710","article-title":"Trust and reciprocity: foundational principles for human subjects imaging research","volume":"34","author":"Illes","year":"2007","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000280469.17461.94","article-title":"Practical approaches to incidental findings in brain imaging research","volume":"70","author":"Illes","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.1124665","article-title":"Incidental findings in brain imaging research","volume":"311","author":"Illes","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0170","series-title":"Treating Dementia: Do We Have a Pill For It?","first-page":"125","article-title":"Making sense of the language of benefit for Alzheimer's disease treatments","author":"Karlawish","year":"2009"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0175","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0180","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","article-title":"Effect of physical activity on cognitive function in older adults at risk for Alzheimer Disease","volume":"300","author":"Lautenschlager","year":"2008","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0185","series-title":"Treating Dementia: Do We Have a Pill For It?","first-page":"231","article-title":"APOE genotyping, risk estimates, and public understanding of susceptibility genes","author":"Lock","year":"2009"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","article-title":"Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results","volume":"5","author":"Meinert","year":"2009","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0205","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.69.5.574","article-title":"Psychological impact of genetic testing for Huntington's disease: an update of the literature","volume":"69","author":"Meiser","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results","volume":"304","author":"MRC Working Party","year":"1992","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0215","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.294.20.joc50147","article-title":"Effect of muraglitazar on death and major adverse cardiovascular events in patients with Type 2 diabetes mellitus","volume":"294","author":"Nissen","year":"2005","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0220","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd2676","article-title":"Mixed results for disease-modification strategies for Alzheimer's disease","volume":"7","author":"Opar","year":"2008","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0235","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepzil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0240","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/gps.2640","article-title":"PET imaging of brain amyloid in dementia: a review","volume":"26","author":"Quigley","year":"2011","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","article-title":"Alzheimer's Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible","volume":"4","author":"Reiman","year":"2010","journal-title":"Biomarkers in Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/01.wnl.0000303973.71803.81","article-title":"Biochemical markers in persons with preclinical familial Alzheimer disease","volume":"71","author":"Ringman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0260","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0265","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/er.2001-7002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis","volume":"23","author":"Shea","year":"2002","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0270","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0275","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0290","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1001\/archneur.58.11.1828","article-title":"Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia","volume":"58","author":"Steinbart","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0295","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1076\/clin.14.4.504.7200","article-title":"Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues","volume":"14","author":"Tuokko","year":"2000","journal-title":"Clinical Neuropsychology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0300","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.22608","article-title":"Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data","volume":"70","author":"Vlassenko","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.12.001_bib0305","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1752-8062.2009.00121.x","article-title":"Translational medicine lessons from Flurizan's failure in Alzheimer's Disease (AD) trial: implication for future drug discovery and development for AD","volume":"2","author":"Wan","year":"2009","journal-title":"Clinical and Translational Science"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212001827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212001827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T06:59:14Z","timestamp":1539932354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008212001827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":60,"alternative-id":["S0301008212001827"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2012.12.001","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}